ThermoGenesis Holdings logo

ThermoGenesis HoldingsNASDAQ: THMO

Profile

Sector:

Healthcare

Country:

United States

IPO:

05 June 1987

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$3.98 K
-99%vs. 3y high
1%vs. sector
-vs. 3y high
-vs. sector
-100%vs. 3y high
17%vs. sector
-100%vs. 3y high
1%vs. sector

Price

regular market | Wed, 23 Oct 2024 13:30:00 GMT
$0.00$0.00(0.00%)

Dividend

No data over the past 3 years
$2.74 M$4.10 M
$2.74 M-$1.86 M

Analysts recommendations

Institutional Ownership

THMO Latest News

ThermoGenesis Holdings, Inc. (THMO) Q3 2023 Earnings Call Transcript
Seeking Alpha13 November 2023 Sentiment: NEUTRAL

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications, IR Dr. Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day.

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update
PRNewsWire08 August 2023 Sentiment: POSITIVE

Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif. , Aug. 8, 2023 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading.

ThermoGenesis Holdings, Inc. (THMO) Q1 2023 Earnings Call Transcript
Seeking Alpha15 May 2023 Sentiment: POSITIVE

ThermoGenesis Holdings, Inc. (NASDAQ:THMO ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Paula Schwartz - Rx Communications Chris Xu - Chief Executive Officer Jeff Cauble - Chief Financial Officer Conference Call Participants Sean Lee - H.C. Wainwright Operator Good day, and welcome to the ThermoGenesis Holdings Conference Call and Webcast to review Financial and Operating Results for the First Quarter ended March 31, 2023.

What type of business is ThermoGenesis Holdings?

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

What sector is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Healthcare sector

What industry is ThermoGenesis Holdings in?

ThermoGenesis Holdings is in the Medical Devices industry

What country is ThermoGenesis Holdings from?

ThermoGenesis Holdings is headquartered in United States

When did ThermoGenesis Holdings go public?

ThermoGenesis Holdings initial public offering (IPO) was on 05 June 1987

What is ThermoGenesis Holdings website?

https://www.thermogenesis.com

Is ThermoGenesis Holdings in the S&P 500?

No, ThermoGenesis Holdings is not included in the S&P 500 index

Is ThermoGenesis Holdings in the NASDAQ 100?

No, ThermoGenesis Holdings is not included in the NASDAQ 100 index

Is ThermoGenesis Holdings in the Dow Jones?

No, ThermoGenesis Holdings is not included in the Dow Jones index

When was ThermoGenesis Holdings the previous earnings report?

No data

When does ThermoGenesis Holdings earnings report?

Next earnings report date is not announced yet